Kumiko Takeuchi

1.4k total citations
31 papers, 1.0k citations indexed

About

Kumiko Takeuchi is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kumiko Takeuchi has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kumiko Takeuchi's work include Asymmetric Synthesis and Catalysis (5 papers), Receptor Mechanisms and Signaling (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Kumiko Takeuchi is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Receptor Mechanisms and Signaling (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Kumiko Takeuchi collaborates with scholars based in United States and Japan. Kumiko Takeuchi's co-authors include Mitsuko Numazaki, Makoto Tominaga, Tomoko Tominaga, Hidenori Toyooka, Namie Murayama, Yoshihisa Shitara, Toshiharu Horie, Steven D. Burke, Jeffery E. Cobb and Todd J. Kohn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Kumiko Takeuchi

31 papers receiving 977 citations

Peers

Kumiko Takeuchi
Comparison fields: 5 of 86
  • Molecular Biology 433
  • Cellular and Molecular Neuroscience 234
  • Sensory Systems 234
  • Organic Chemistry 207
  • Physiology 135
Albert Jaxa‐Chamiec United Kingdom
Wolfram Hänsel Germany
Nigel A. Swain United Kingdom
Hiroyuki Masayasu Japan
B Berthon France
Mark E. McDonnell United States
Stefania Baraldi Italy
A. Müller Germany
Sharan K. Bagal United Kingdom
Marino Convertino United States
Albert Jaxa‐Chamiec United Kingdom View profile →
Citations per field, relative to Kumiko Takeuchi
Kumiko Takeuchi · 1×
Citations per year, relative to Kumiko Takeuchi
Kumiko Takeuchi · 1×

Countries citing papers authored by Kumiko Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Kumiko Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumiko Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumiko Takeuchi more than expected).

Fields of papers citing papers by Kumiko Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumiko Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumiko Takeuchi. The network helps show where Kumiko Takeuchi may publish in the future.

Co-authorship network of co-authors of Kumiko Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kumiko Takeuchi. A scholar is included among the top collaborators of Kumiko Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumiko Takeuchi. Kumiko Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 CHAC1 exacerbates arsenite cytotoxicity by lowering intracellular glutathione levels The Journal of Toxicological Sciences Daigo Sumi, Hiroki Taguchi et al. 4
2 Long-Lasting Inhibitory Effects of Saquinavir and Ritonavir on OATP1B1-Mediated Uptake Journal of Pharmaceutical Sciences Yoshihisa Shitara, Kumiko Takeuchi et al. 35
3 Long-lasting Inhibitory Effects of Cyclosporin A, but Not Tacrolimus, on OATP1B1- and OATP1B3-mediated Uptake Drug Metabolism and Pharmacokinetics Yoshihisa Shitara, Kumiko Takeuchi et al. 71
4 Structure–activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1 Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Jamie H. McKinzie et al. 9
5 Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2 Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Charles H. Mitch et al. 10
6 A Toxicogenomic Approach Revealed Hepatic Gene Expression Changes Mechanistically Linked to Drug-Induced Hemolytic Anemia Toxicological Sciences Masatomo Rokushima, Akiko Araki et al. 14
7 Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5 Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 17
8 Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and Phospholipid Journal of Biological Chemistry Kentaro Tsukamoto, Tomoko Kohda et al. 110
9 Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4 Bioorganic & Medicinal Chemistry Letters Vincent P. Rocco, Todd J. Kohn et al. 30
10 Fission yeast epsin, Ent1p is required for endocytosis and involved in actin organization. PubMed Chika Sakamoto, Kumiko Takeuchi et al. 4
11 DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src‐dependent manner The EMBO Journal Wenxiang Meng, Mitsuko Numazaki et al. 62
12 Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3 Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 18
13 Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1 Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 45
14 Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2 Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 20
15 1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Donetta S. Gifford‐Moore et al. 28
16 Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. Part 6: Further focus on the contracted C4′-side chain analogues Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 3
17 Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[b]thiophenes Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 28
18 Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 2. Design, synthesis, and evaluation of a novel series of phenyl oxazole derivatives Bioorganic & Medicinal Chemistry Letters Kumiko Takeuchi, Todd J. Kohn et al. 6
19 Neovibsanines A and B, unprecedented diterpenes from Viburnum awabuki Tetrahedron Letters Yoshiyasu Fukuyama, Hiroyuki Minami et al. 47
20 Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition-I. Synthesis, structure-activity relationship, and evaluation of substituted (ω-phenyl-ω)-(3-pyridyl)alkenoic acids Bioorganic & Medicinal Chemistry Kumiko Takeuchi, Dale E. Mais et al. 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026